Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 iExec RLC iExec RLC +20.53%
#5 CyberDEX CyberDEX +19.21%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Kedudukan dalam Saham #34017
Clinical Laserthermia Systems AB (publ) engages in the development of treatment... Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Harga Saham
$0.19568707
Modal Pasaran
$6.16M
Perubahan (1 hari)
0.92%
Perubahan (1 tahun)
-77.17%
Negara
SE
Perdagangan Clinical Laserthermia Systems AB (publ) (CLS-B)

Kategori

Healthcare
Nisbah P/E bagi Clinical Laserthermia Systems AB (publ) (CLS-B)
Nisbah P/E pada October 2026 TTM: -1.37
Menurut laporan kewangan dan harga saham terkini Clinical Laserthermia Systems AB (publ), nisbah P/E semasa (TTM) ialah -1.37. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -1.16.
Sejarah nisbah P/E bagi Clinical Laserthermia Systems AB (publ) dari 2008 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -1.37 61.22%
2024 -0.85 -27.17%
2023 -1.16 15.77%
2022 -1.00 -72.89%
2021 -3.70 5.14%
2020 -3.52 -26.19%
2019 -4.77 -26.87%
2018 -6.52 -67.78%
2017 -20.25 141.77%
2016 -8.38 -21.66%
2015 -10.69 42.64%
2014 -7.50 -49.75%
2013 -14.92 -99.55%
2012 -3.35K -61.32%
2011 -8.65K -28.04%
2010 -12.02K -14.03%
2009 -13.98K 5,171.83%
2008 -265.26 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
STERIS plc STERIS plc
STERIS plc
STE.US
 25.61 -1,968.87%
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
 - -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
 - -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
 - -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
 - -
CN
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.